Activities of daily living (ADL) are a complex system of activities required for functional independence and everyday functioning. Problems in complex ADLs, necessary to interact with others in the society are recognized to represents the first signs of cognitive loss up to dementia associated with different neurodegenerative pathologies. There was a dynamic growth in knowledge encompassing successfully ageing people and patient groups with different neurodegenerative diseases. Moreover, a variety of quantitative and qualitative testing methods are available contributing to the early diagnosis of different neurodegenerative diseases. The current research topic has a focus delineate the major advances in the theory of ADL, ADL measurement methods as well as specific new results in successful ageing and different clinical populations.
The goal of the present Research Topic is as follows:
– To describe major advances in the theory of ADL in successful and abnormal ageing
– To delineate the evolution of different approaches to ADL measurement, e.g., direct observation, performance-based measures, and self-and informant-report questionnaires
– To describe new findings advancing the diagnostic process in clinical populations with a special focus on neurodegenerative diseases (e.g., AD, PD, FTLD, and others)
– To analyze the development of novel, disease-specific measures for ADL in neurodegenerative disorders?
– To put at test some recent theories of ADL, e.g., the processing speed theory of activities of daily living in healthy aging
Scope and information for Authors:
• The theory and concept of ADL
• Critical discussion of qualitative and quantitative ADL assessments for early and differential diagnosis of neurodegenerative disorders
• Diagnostic advances and precision in ADL measurement
• ADL profile in healthy/normal/successful ageing and neurodegenerative disorders
• Factors interacting with ADL measures and limitation of quantitative assessments
• ADL as outcome measures of neurodegenerative diseases • Assessment tools to evaluate ADL in neurodegenerative diseases
• Technology objective measures for ADL in neurodegenerative diseases
Activities of daily living (ADL) are a complex system of activities required for functional independence and everyday functioning. Problems in complex ADLs, necessary to interact with others in the society are recognized to represents the first signs of cognitive loss up to dementia associated with different neurodegenerative pathologies. There was a dynamic growth in knowledge encompassing successfully ageing people and patient groups with different neurodegenerative diseases. Moreover, a variety of quantitative and qualitative testing methods are available contributing to the early diagnosis of different neurodegenerative diseases. The current research topic has a focus delineate the major advances in the theory of ADL, ADL measurement methods as well as specific new results in successful ageing and different clinical populations.
The goal of the present Research Topic is as follows:
– To describe major advances in the theory of ADL in successful and abnormal ageing
– To delineate the evolution of different approaches to ADL measurement, e.g., direct observation, performance-based measures, and self-and informant-report questionnaires
– To describe new findings advancing the diagnostic process in clinical populations with a special focus on neurodegenerative diseases (e.g., AD, PD, FTLD, and others)
– To analyze the development of novel, disease-specific measures for ADL in neurodegenerative disorders?
– To put at test some recent theories of ADL, e.g., the processing speed theory of activities of daily living in healthy aging
Scope and information for Authors:
• The theory and concept of ADL
• Critical discussion of qualitative and quantitative ADL assessments for early and differential diagnosis of neurodegenerative disorders
• Diagnostic advances and precision in ADL measurement
• ADL profile in healthy/normal/successful ageing and neurodegenerative disorders
• Factors interacting with ADL measures and limitation of quantitative assessments
• ADL as outcome measures of neurodegenerative diseases • Assessment tools to evaluate ADL in neurodegenerative diseases
• Technology objective measures for ADL in neurodegenerative diseases
